Lung Cancer Management
Initial Diagnostic Approach
- The American College of Chest Physicians recommends that every patient suspected of having lung cancer must undergo chest CT scanning as the initial imaging modality, which provides superior characterization of pulmonary lesions compared to chest radiography alone 1, 3
- The British Journal of Cancer suggests that the chest CT scan structures the subsequent diagnostic and staging evaluation by defining the clinical diagnosis and identifying features suggesting metastatic disease 1
- Pay specific attention to organ-specific symptoms (bone pain, neurologic changes) and constitutional symptoms (fatigue, anorexia, weight loss >5%) that indicate potential metastatic spread, as recommended by the American College of Chest Physicians 1
Tissue Diagnosis
- The British Journal of Cancer and the Annals of Oncology recommend obtaining histopathological confirmation using bronchoscopy, transthoracic needle biopsy (Tru-cut preferred for larger tissue samples), or surgical biopsy according to lesion location and accessibility 3, 2
- The Annals of Oncology suggests that immunohistochemistry should be used to subtype NSCLC (TTF1 for adenocarcinoma, p40 for squamous cell carcinoma), keeping NSCLC-NOS diagnoses below 10% of cases 2
- The Annals of Oncology recommends conserving tissue at every diagnostic stage—using only two sections for IHC subtyping to preserve material for molecular testing 2
Molecular and Biomarker Testing
- The Annals of Oncology recommends that for all patients with advanced NSCLC, molecular testing for targetable oncogenic alterations (EGFR, ALK, ROS1, BRAF, MET, RET, NTRK) and PD-L1 expression testing should be performed 2
Staging
- The American College of Chest Physicians suggests that PET imaging plays a prominent role in staging, particularly for identifying occult metastatic disease, and should be performed in most patients beyond very early-stage disease 1
- The British Journal of Cancer recommends that patients separate into four management categories based on chest CT findings: resectable early-stage, locally advanced, metastatic, and indeterminate nodules requiring further characterization 1
Treatment by Stage and Histology
- The Annals of Oncology recommends that surgery remains the standard treatment with curative intent for patients with resectable stage I-II NSCLC 5
- The British Journal of Cancer suggests that lobectomy is the standard surgical approach; segmentectomy may be considered only in elderly patients or those with severe respiratory insufficiency 3, 6
- The Annals of Oncology recommends that for adjuvant treatment following resection and platinum-based chemotherapy in stage IB (T2a ≥4 cm), II, or IIIA NSCLC, pembrolizumab or other treatments may be considered, however the specific details are not provided in the cited reference 5
Supportive and Palliative Care
- The American College of Chest Physicians recommends that for all patients with stage IV lung cancer and/or high symptom burden, introduce palliative care combined with standard oncology care early in the treatment course 7, 8
- The American College of Chest Physicians suggests that this approach should begin at diagnosis rather than being delayed until death is imminent 7, 8
- The American College of Chest Physicians recommends performing comprehensive biopsychosocial assessment soon after diagnosis and at key transition points (treatment completion, disease progression, new symptom onset) 8, 7
- The American College of Chest Physicians suggests addressing psychological symptoms (depression, anxiety) with antidepressants, anxiolytics, or psychostimulants as indicated 8, 7
- The American College of Chest Physicians recommends that for insomnia, prescribe sedating antidepressants rather than sedative-hypnotics as they address both sleep and mood disturbances 7
- The American College of Chest Physicians suggests that for breathlessness, implement interventions using psychological coping and physical adaptation strategies, which are more effective than routine office visits 7
- The American College of Chest Physicians recommends that for symptomatic malignant pleural effusion, tunneled catheters are recommended for symptom relief and quality of life improvement 8
- The American College of Chest Physicians suggests that when diagnosis of stage IV disease is not confirmed, perform thoracoscopy instead of tunneled catheter placement for both diagnostic and therapeutic benefit 8
- The American College of Chest Physicians recommends using graded talc as the pleural sclerosant via thoracoscopy with talc poudrage rather than talc slurry through bedside chest tube (if no contraindications to thoracoscopy) 8, 7